1. Home
  2. KURA vs CHCO Comparison

KURA vs CHCO Comparison

Compare KURA & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

N/A

Current Price

$10.63

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo City Holding Company

CHCO

City Holding Company

N/A

Current Price

$140.66

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KURA
CHCO
Founded
2014
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
2.1B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
KURA
CHCO
Price
$10.63
$140.66
Analyst Decision
Strong Buy
Hold
Analyst Count
15
5
Target Price
$32.00
★ $140.40
AVG Volume (30 Days)
★ 1.6M
79.3K
Earning Date
11-03-2026
10-21-2026
Dividend Yield
N/A
★ 2.50%
EPS Growth
N/A
★ 13.18
EPS
N/A
★ 4.55
Revenue
★ $67,482,000.00
N/A
Revenue This Year
$43.11
$4.29
Revenue Next Year
$119.71
$3.11
P/E Ratio
★ N/A
$30.70
Revenue Growth
★ 25.24
N/A
52 Week Low
$7.36
$113.21
52 Week High
$13.90
$148.99

Technical Indicators

Market Signals
Indicator
KURA
CHCO
Relative Strength Index (RSI) 44.32 34.05
Support Level $8.45 $120.03
Resistance Level $11.40 $147.26
Average True Range (ATR) 0.45 2.45
MACD -0.13 -0.50
Stochastic Oscillator 34.24 1.32

Price Performance

Historical Comparison
KURA
CHCO

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: